• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Implications of the most bothersome prostatism symptom for clinical care and outcomes research.

作者信息

DuBeau C E, Yalla S V, Resnick N M

机构信息

Gerontology Division, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

J Am Geriatr Soc. 1995 Sep;43(9):985-92. doi: 10.1111/j.1532-5415.1995.tb05562.x.

DOI:10.1111/j.1532-5415.1995.tb05562.x
PMID:7544816
Abstract

OBJECTIVES

Because treatment of benign prostatic hyperplasia (BPH) is based largely on patients' symptoms, understanding and measuring the impact of these symptoms from the patient's perspective is critically important for clinical care. Such knowledge also is crucial for comparing patient-weighted outcomes because the increasing array of medical and surgical BPH treatments differ in their impact on specific symptoms. Our purpose was to determine the most bothersome symptom in older men seeking evaluation for symptomatic BPH and to examine whether age, comorbidity, or urodynamic evidence of prostatic obstruction were important covariates.

DESIGN

Prospective evaluation of a consecutive series.

SETTING

Veterans Affairs urology clinic.

PARTICIPANTS

115 men (age 69 +/- 6 years) presenting for initial evaluation of prostatism.

MEASUREMENTS

Scores on standard symptom index and patients' reports of the most bothersome symptom. Bladder outlet obstruction was assessed by multichannel videourodynamic evaluation.

RESULTS

An "irritative" symptom (frequency, urgency, or nocturia) was cited as most bothersome significantly more often than an "obstructive" symptom (weak stream, hesitancy, etc.) (53 vs. 35%, P < .05); older men were significantly more likely to name an irritative symptom as most bothersome (chi 2 for trend = 6.63, P < .025). Even among men with prostate obstruction, most cited an irritative symptom as the most bothersome, regardless of the severity of obstruction. These associations were not confounded by comorbid conditions or medications that independently may cause symptoms.

CONCLUSIONS

Because irritative symptoms are most bothersome, have a diverse differential diagnosis, and do not respond as well to BPH treatment, neither providers nor researchers should rely solely on global assessments of symptom severity and bother in assessing men with voiding symptoms. Additional focus on individual symptom impact and etiology is needed, especially in older men.

摘要

相似文献

1
Implications of the most bothersome prostatism symptom for clinical care and outcomes research.
J Am Geriatr Soc. 1995 Sep;43(9):985-92. doi: 10.1111/j.1532-5415.1995.tb05562.x.
2
Impact of symptoms of prostatism on level of bother and quality of life of men in the French community.前列腺增生症状对法国社区男性困扰程度及生活质量的影响。
J Urol. 1995 Mar;153(3 Pt 1):669-73. doi: 10.1097/00005392-199503000-00033.
3
Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.盐酸坦索罗辛对良性前列腺增生患者下尿路症状及生活质量的影响。采用困扰评分进行评估。
Drugs Today (Barc). 2007 Jun;43 Suppl B:1-7.
4
'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.
Br J Urol. 1994 Nov;74(5):542-50. doi: 10.1111/j.1464-410x.1994.tb09181.x.
5
Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.美国泌尿外科学会症状指数与梗阻性和非梗阻性前列腺增生的相关性。
J Urol. 1995 Mar;153(3 Pt 1):674-9; discussion 679-80.
6
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.男性下尿路症状提示良性前列腺增生伴射精功能障碍。
BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7.
7
Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.国际前列腺症状评分与压力-流率研究在有症状良性前列腺增生评估中的相关性
J Urol. 1996 Jan;155(1):200-2. doi: 10.1097/00005392-199601000-00072.
8
Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.良性前列腺增生影响指数(BII)的内容效度;衡量尿路问题和与 BPH 相关的问题可能对患者造成的影响。
Int J Clin Pract. 2012 Sep;66(9):883-90. doi: 10.1111/j.1742-1241.2012.02960.x.
9
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
10
Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.在临床实践环境中,国际前列腺症状评分困扰问题与良性前列腺增生影响指数的相关性。
BJU Int. 2008 Jun;101(12):1531-5. doi: 10.1111/j.1464-410X.2008.07574.x. Epub 2008 Apr 28.

引用本文的文献

1
Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction.视频尿动力学检查在下尿路功能障碍精准诊断与治疗中的作用
Tzu Chi Med J. 2019 Nov 18;32(2):121-130. doi: 10.4103/tcmj.tcmj_178_19. eCollection 2020 Apr-Jun.
2
Nocturia: Finding an Identity.夜尿症:寻找其特征
Rev Urol. 2018;20(4):170-173. doi: 10.3909/riu0822.
3
Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them?当前临床实践中夜尿症的诊断和管理:哪些是夜尿症患者,我们如何治疗他们?
World J Urol. 2019 Jul;37(7):1389-1394. doi: 10.1007/s00345-018-2511-4. Epub 2018 Oct 4.
4
Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: A Cross-sectional, Population-based Study.按年龄和性别划分的夜尿症与睡眠功能结局之间关联的差异:一项基于人群的横断面研究。
Clin Ther. 2016 Nov;38(11):2386-2393.e1. doi: 10.1016/j.clinthera.2016.09.009. Epub 2016 Oct 15.
5
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.前列腺癌立体定向体部放射治疗3年后刺激性排尿症状改善。
Front Oncol. 2014 Oct 21;4:290. doi: 10.3389/fonc.2014.00290. eCollection 2014.
6
Age related change of nocturia in women.女性夜尿症与年龄的相关性变化。
Int Neurourol J. 2010 Dec;14(4):245-9. doi: 10.5213/inj.2010.14.4.245. Epub 2010 Dec 31.
7
Prevalence and correlates of nocturia in community-dwelling older adults.社区居住的老年人群中夜尿症的流行率及其相关因素。
J Am Geriatr Soc. 2010 May;58(5):861-6. doi: 10.1111/j.1532-5415.2010.02822.x. Epub 2010 Apr 14.
8
α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume.α(1)-肾上腺素受体阻滞剂萘哌地尔可改善睡眠障碍,减少夜间尿量。
World J Urol. 2011 Apr;29(2):233-8. doi: 10.1007/s00345-010-0544-4. Epub 2010 Apr 13.